In CTC-FAST project, we aim to improve the detection of circulating tumor cells (CTCs) by replacing the antibody based detection assay with DNA based one. Accordingly, we designed the folic acid (FA) conjugated DNA tetrahedrons to capture CTCs from the blood sample. To anchor the DNA tetrahedrons in our automatic device, we decided to apply the zinc finger fusion protein Zif268-PBSII, which will be coated on the main chamber of our device to interact with the corresponding motifs at the edge of DNA tetrahedron. To produce the tetrahedral ssDNA with highly complementary sequences in vivo, we construct the rolling circle replication (RCR) system in E. coli. Finally, to label the captured CTCs, we used the new fluorescence protein, mGreenLatern (mGL), which has a stronger brightness than canonical eGFP, to increase the sensitivity.
To examine whether the DNA tetrahedron could be assembled by single-stranded DNA (ssDNA) in a complementary manner, we designed four ssDNAs TD-1, TD-2, TD-3 and TD-4
(Sequences are shown in design) and performed the tetrahedron assembly according to the standard annealing protocol.
After annealing, the reaction mixture was subjected into native PAGE electrophoresis. The product size of annealing two ssDNAs (TD-1+TD-2 and TD-2+TD-3) was around 80 bp, while annealing three ssDNAs (TD-1+TD-3+TD-4 and TD-2+TD-3+TD-4) was around 120 bp. The product sizes of annealing two or three ssDNA were slightly smaller than anticipation, which may result from the partial complementation. Importantly, the product size of annealing four ssDNAs was 175 bp, suggesting a more completely complementation. However, we also observed the side product with size more than 175 bp, which may stand for the DNA polyhedrons.
▲ Fig. 1: The native PAGE analysis of annealing ssDNAs following the standard protocol.
▲ Fig. 2: The native PAGE analysis of annealing ssDNAs with different Mg2+ concentration.
▲ Fig. 3:The native PAGE analysis of tetrahedron assembly by gradually cooling down.
To rescue the random complementation, we decided to fuse the four ssDNAs into single tetrahedral ssDNA for tetrahedron assembly. Because of the reverse polarity of complementary DNA strands, one edge of the tetrahedron must form the “twin double helices” structure
(See design for detail). We decided to generate the double-stranded DNA (dsDNA) encoding tetrahedral sequence as a template and performed in vitro rolling circle amplification (RCA) to produce the tetrahedral ssDNA. However, the serious problem is that the production of dsDNA templates with highly complementary sequences are rejected by most companies. To put the tetrahedral dsDNA template into order, we separated the dsDNA template into two parts (ssDNA-L and ssDNA-R) and added an extra stuffer to reduce the complementarity.
▲ Fig. 4: The drawing shows how we add stuffer and separate tetrahedral ssDNA to reduce the complementarity.
▲ Fig. 5: The electrogram shows the sequence of fused ssDNA-L and ssDNA-R
According to the suggestion from experts, we decided to construct the RCR system in E.coli to generate circular tetrahedral ssDNAs from the dsDNA template and coexpress ssDNA binding protein (SSBP) to block the polyhedrons formation.
▲ Fig. 6: The design of RCR mediated circular ssDNA generation
▲ Fig. 7: The electrogram shows the successful insertion of target cassette (BBa_K4674012)
▲ Fig. 8: The electrogram shows the successful insertion of RepA and SSBP expression cassette (BBa_K4674011)
▲ Fig. 9: The coomassie blue staining of SDS-PAGE analysis of RepA and SSBP protein induction. S: supernatant; P: cell pellet.
To conjugate the folic acid to the adaptor ssDNA for CTC capture, we utilized the mechanism of SN2 reaction to prepare FA-NHS ester. Following the
protocol of generating FA-NHS ester, we observed the expected pale yellow substance.
▲ Fig. 10: The folic acid NHS ester shows pale yellow feature.
▲ Fig. 11: The folic acid NHS ester IR spectra compare with SDBS
▲ Fig.12: The absorption spectra of FA-ssDNA and ssDNA
To anchor the DNA tetrahedrons in our automatic device, we applied the specific interaction between zinc finger fusion protein (PBSII-Zif268) and its corresponding motifs at the edge of the tetrahedron
(see designfor details). To express the PBSII-Zif268 fusion protein, we design the composite part
and clone it into pET-15b plasmid. The sequencing result confirmed the correct insertion of
BBa_K4674013 in the pET-15b vector.
▲ Fig. 13:The electrogram shows the successful insertion of PBSII-Zif268 expression cassette.
▲ Fig. 14: The coomassie blue staining of SDS-PAGE analysis of PBSII-Zif268 fusion protein induced at different temperatures and IPTG concentrations. Sup: supernatant; P: pellet
▲ Fig. 15: The coomassie blue staining of SDS-PAGE analysis of PBSII-Zif268 fusion protein extracted from the inclusion body. Sup 2: the urea-soluble supernatant; P2: the urea-insoluble pellet
To examine whether the mGL-4A-C7 protein is functional in labeling CTCs as the modeling result, we builded the composite part
(BBa_K4674010)
for mGL-4A-C7 protein expression. As a control, we also builded the composite part
(BBa_K4674009) for eGFP-4A-C7 protein expression.
After confirming the expression cassette insertion into pET-15b, we induced the mGL-4A-C7 and eGFP-4A-C7 protein expression by adding 1mM IPTG at 37°C. The Coomassie blue staining of PAGE analysis clearly showed that the induced mGL-4A-C7 and eGFP-4A-C7 protein was soluble and could be purified by Ni2+ beads.
▲ Fig. 16: The coomassie blue staining of SDS-PAGE analysis of mGL-4A-C7 and eGFP-4A-C7 protein induced by IPTG.
▲ Fig. 17: The 280 nm absorption spectra of proteins eluted from mGL-4A-C7 purification.
▲ Fig. 18: The coomassie blue staining of SDS-PAGE analysis of fractions from FPLC elution.
▲ Fig. 19: The fluorescence detection of rehydrated mGL-4A-C7 and eGFP-4A-C7 stored at room temperature using the standard eGFP filter.
Incubate 2hr | ||||
---|---|---|---|---|
control | 50 μg/mL | 100 μg/mL | 200 μg/mL | |
nucleus |
|
|
|
|
eGFP-4A-C7 |
|
|
|
|
Merge |
|
|
|
|
control | 50 μg/mL | 100 μg/mL | 200 μg/mL | |
nucleus |
|
|
|
|
mGL-4A-C7 |
|
|
|
|
Merge |
|
|
|
|
Incubate 4hr | ||||
---|---|---|---|---|
control | 50 μg/mL | 100 μg/mL | 200 μg/mL | |
nucleus |
|
|
|
|
eGFP-4A-C7 |
|
|
|
|
Merge |
|
|
|
|
control | 50 μg/mL | 100 μg/mL | 200 μg/mL | |
nucleus |
|
|
|
|
mGL-4A-C7 |
|
|
|
|
Merge |
|
|
|
|